MONA KAMEL EED QUSHAWY

Mona Kamel Qushawy, PhD Assistant professor, Pharmaceutics Department, Faculty of Pharmacy, Tabuk University, Tabuk, Saudi Arabia

Resume

Study Schedule

Research And Literature

Research Projects

Awards

Day	Course	Time
الأحد	Pharmaceutical field training 3 (PDFT 0513) 5th year	08:00 - 15:00
الإثنين	Academic advising	10:00 - 12:00
الإثنين	Office hour	12:00 - 13:00
الثلاثاء	Academic advising	10:00 - 12:00
الثلاثاء	Office hour	12:00 - 13:00
الثلاثاء	Clinical biochemistry (PDPC 0432), 4th year	13:00 - 15:00
الأربعاء	Pharmaceutics-1 (PDPH 0331) 3rd year	08:00 - 10:00
الأربعاء	Academic advising	10:00 - 12:00
الأربعاء	Pharmaceutics-1 (PDPH 0331) 3rd year practical	12:00 - 14:00
الخميس	Pharmaceutical calculations (PDPH 0211), 2nd	09:00 - 12:00
الخميس	Office hour	12:00 - 13:00

Ahmed A, Ghourab M, Gad S, Qushawy M The application of Plackett-Burman design and response surface methodology for optimization of formulation variables to produce Piroxicam niosomes Int J Drug Dev Res 2013 Apr5(2):121-30
Ahmed A, Ghourab M, Shedid S, Qushawy M Optimization of piroxicam niosomes using central composite design Int J Pharm Pharm Sci 20135(3):229-36
Gad S, Ahmed AM, Ghourab MM, Qushawy MK Design, formulation, and evaluation of Piroxicam niosomal gel Int J Pharmtech Res 20146:185-95
Qushawy M, Nasr A, Abd-Alhaseeb M, Swidan S Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections Pharmaceutics 2018 Mar10(1):26
Gardouh AR, Barakat BM, Qushawy MK, El-Kazzaz AY, Sami MM, Zaitone SA Antitumor activity of a molecularly imprinted nanopreparation of 5-flurouracil against Ehrlichs carcinoma solid tumors grown in mice: Comparison to free 5-flurouracil Chemico-Biological Interactions 2018 Nov 1295:52-63
Nasr A, Qushawy M, Swidan S Spray Dried Lactose Based Proniosomes as Stable Provesicular Drug Delivery Carriers: Screening, Formulation, and Physicochemical Characterization Int J Appl Pharm 201810:125
Qushawy M, Prabahar K, Abd-Alhaseeb M, Swidan S, Nasr A Preparation and Evaluation of Carbamazepine Solid Lipid Nanoparticle for Alleviating Seizure Activity in Pentylenetetrazole-Kindled Mice Molecules 2019 Jan24(21):3971
Qushawy M, Nasr A Solid lipid nanoparticles (SLNs) as nano drug delivery carriers: preparation, characterization and application Int J App Pharm 202012(1):1-9
Prabahar K, Udhumansha U, Qushawy M Optimization of Thiolated Chitosan Nanoparticles for the Enhancement of in Vivo Hypoglycemic Efficacy of Sitagliptin in Streptozotocin-Induced Diabetic Rats Pharmaceutics 2020 Apr12(4):300
Alsharef S, Alanazi M, Alharthi F, Qandil D, Qushawy M Review ‎about radiopharmaceuticals: preparation, radioactivity, and ‎applications Int J App Pharm 202012(3):8-15‎
Nasr AM, Qushawy MK, Elkhoudary MM, Gawish AY, Elhady SS, Swidan SA Quality by Design for the Development and Analysis of Enhanced In-Situ Forming Vesicles for the Improvement of the Bioavailability of Fexofenadine HCl in Vitro and in Vivo Pharmaceutics 2020 May12(5):409
Gardouh AR, Attia MA, Enan ET, Elbahaie AM, Fouad RA, El-Shafey M, Youssef AM, Alomar SY, Ali ZA, Zaitone SA, Qushawy MK Synthesis and Antitumor Activity of Doxycycline Polymeric Nanoparticles: Effect on Tumor Apoptosis in Solid Ehrlich Carcinoma Molecules 2020 Jan25(14):3230
Qushawy M, Nasr A, Swidan S, Mortagi Y Development and Characterization of Glimepiride Novel Solid Nanodispersion for Improving Its Oral Bioavailability Scientia Pharmaceutica 2020 Dec88(4):52
Fahmy EK, El-Sherbiny M, Said E, Elkattawy HA, Qushawy M, Elsherbiny N Tranilast ameliorated subchronic silver nanoparticles-induced cerebral toxicity in rats: Effect on TLR4/NLRP3 and Nrf-2 NeuroToxicology 2020 Dec 1982:167-76
Alzahrani S, Said E, Ajwah SM, Alsharif SY, El-Bayoumi KS, Zaitone SA, Qushawy M, Elsherbiny NM Isoliquiritigenin attenuates inflammation and modulates Nrf2/caspase-3 signalling in STZ-induced aortic injury Journal of Pharmacy and Pharmacology 2021 Jan 13
Nagy MI, Darwish KM, Kishk SM, Tantawy MA, Nasr AM, Qushawy M, Swidan SA, Mostafa SM, Salama I Design, Synthesis, Anticancer Activity, and Solid Lipid Nanoparticle Formulation of Indole- and Benzimidazole-Based Compounds as Pro-Apoptotic Agents Targeting Bcl-2 Protein Pharmaceuticals 2021 Jan 14(2):113
Qushawy M Effect of The Surfactant and Liquid Lipid Type in The Physico-chemical Characteristics of Beeswax-based Nanostructured Lipid Carrier (NLC) of Metformin Pharmaceutical Nanotechnology 2021 Feb 22
Prabahar K, Alanazi Z, Qushawy M Targeted Drug Delivery System: Advantages, Carriers and Strategies INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH 2021 Apr 155(2):346-53

Project Name	Project Description
Preparation of carbamazepine as a solid lipid Nano particles for enhancing anti-epileptic effect	S-0109-1439, funded by University of Tabuk, KSA, (2018)
Nano engineered Sitagliptin delivery platform for diabetes,	S-1440-0019, funded by University of Tabuk, KSA, (2019)
Design and devolpment of polymer coated micrineedle-mediated delivery of B-sitosterol for treatment of androgenic alopecia	S-1442-0033, institutional fund, KSA, (2021)

College

Faculty of Pharmacy

General specialization

Drug Delivery Systems

Exact Specialty

Pharmaceutical Nanotechnology

Academic degree (rank)

Doctorate

Nationality

Egyptian

Job Title

Assistant Professor 258-52

Last Modified Date:2025/10/01 - 07:58 AM09/Rabi’ Al-Thani/1447 - 10:58Saudi Arabia Time

Ahmed A, Ghourab M, Gad S, Qushawy M The application of Plackett-Burman design and response surface methodology for optimization of formulation variables to produce Piroxicam niosomes Int J Drug Dev Res 2013 Apr5(2):121-30
Ahmed A, Ghourab M, Shedid S, Qushawy M Optimization of piroxicam niosomes using central composite design Int J Pharm Pharm Sci 20135(3):229-36
Gad S, Ahmed AM, Ghourab MM, Qushawy MK Design, formulation, and evaluation of Piroxicam niosomal gel Int J Pharmtech Res 20146:185-95
Qushawy M, Nasr A, Abd-Alhaseeb M, Swidan S Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections Pharmaceutics 2018 Mar10(1):26
Gardouh AR, Barakat BM, Qushawy MK, El-Kazzaz AY, Sami MM, Zaitone SA Antitumor activity of a molecularly imprinted nanopreparation of 5-flurouracil against Ehrlichs carcinoma solid tumors grown in mice: Comparison to free 5-flurouracil Chemico-Biological Interactions 2018 Nov 1295:52-63
Nasr A, Qushawy M, Swidan S Spray Dried Lactose Based Proniosomes as Stable Provesicular Drug Delivery Carriers: Screening, Formulation, and Physicochemical Characterization Int J Appl Pharm 201810:125
Qushawy M, Prabahar K, Abd-Alhaseeb M, Swidan S, Nasr A Preparation and Evaluation of Carbamazepine Solid Lipid Nanoparticle for Alleviating Seizure Activity in Pentylenetetrazole-Kindled Mice Molecules 2019 Jan24(21):3971
Qushawy M, Nasr A Solid lipid nanoparticles (SLNs) as nano drug delivery carriers: preparation, characterization and application Int J App Pharm 202012(1):1-9
Prabahar K, Udhumansha U, Qushawy M Optimization of Thiolated Chitosan Nanoparticles for the Enhancement of in Vivo Hypoglycemic Efficacy of Sitagliptin in Streptozotocin-Induced Diabetic Rats Pharmaceutics 2020 Apr12(4):300
Alsharef S, Alanazi M, Alharthi F, Qandil D, Qushawy M Review ‎about radiopharmaceuticals: preparation, radioactivity, and ‎applications Int J App Pharm 202012(3):8-15‎
Nasr AM, Qushawy MK, Elkhoudary MM, Gawish AY, Elhady SS, Swidan SA Quality by Design for the Development and Analysis of Enhanced In-Situ Forming Vesicles for the Improvement of the Bioavailability of Fexofenadine HCl in Vitro and in Vivo Pharmaceutics 2020 May12(5):409
Gardouh AR, Attia MA, Enan ET, Elbahaie AM, Fouad RA, El-Shafey M, Youssef AM, Alomar SY, Ali ZA, Zaitone SA, Qushawy MK Synthesis and Antitumor Activity of Doxycycline Polymeric Nanoparticles: Effect on Tumor Apoptosis in Solid Ehrlich Carcinoma Molecules 2020 Jan25(14):3230
Qushawy M, Nasr A, Swidan S, Mortagi Y Development and Characterization of Glimepiride Novel Solid Nanodispersion for Improving Its Oral Bioavailability Scientia Pharmaceutica 2020 Dec88(4):52
Fahmy EK, El-Sherbiny M, Said E, Elkattawy HA, Qushawy M, Elsherbiny N Tranilast ameliorated subchronic silver nanoparticles-induced cerebral toxicity in rats: Effect on TLR4/NLRP3 and Nrf-2 NeuroToxicology 2020 Dec 1982:167-76
Alzahrani S, Said E, Ajwah SM, Alsharif SY, El-Bayoumi KS, Zaitone SA, Qushawy M, Elsherbiny NM Isoliquiritigenin attenuates inflammation and modulates Nrf2/caspase-3 signalling in STZ-induced aortic injury Journal of Pharmacy and Pharmacology 2021 Jan 13
Nagy MI, Darwish KM, Kishk SM, Tantawy MA, Nasr AM, Qushawy M, Swidan SA, Mostafa SM, Salama I Design, Synthesis, Anticancer Activity, and Solid Lipid Nanoparticle Formulation of Indole- and Benzimidazole-Based Compounds as Pro-Apoptotic Agents Targeting Bcl-2 Protein Pharmaceuticals 2021 Jan 14(2):113
Qushawy M Effect of The Surfactant and Liquid Lipid Type in The Physico-chemical Characteristics of Beeswax-based Nanostructured Lipid Carrier (NLC) of Metformin Pharmaceutical Nanotechnology 2021 Feb 22
Prabahar K, Alanazi Z, Qushawy M Targeted Drug Delivery System: Advantages, Carriers and Strategies INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH 2021 Apr 155(2):346-53

mqushawy@ut.edu.sa

MONA KAMEL EED QUSHAWY

Follow Us on